HERON THERAPEUTICS, INC. /DE/ Operating Lease, Liability, Noncurrent
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Operating Lease, Liability, Noncurrent of $5.50 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability, Noncurrent $5.50M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $0.00.
- 2024-09-30: Operating Lease, Liability, Noncurrent $522.00K.
- 2024-06-30: Operating Lease, Liability, Noncurrent $1.29M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $5.50M 10-Q · filed 2026-08-10 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-10 |
| 2024-09-30 | $522.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.29M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $2.04M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $2.80M 10-K · filed 2025-02-27 |
| 2023-09-30 | $3.54M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $4.16M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $4.83M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.50M 10-K · filed 2024-03-12 |
| 2022-09-30 | $6.15M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $6.78M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $7.39M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $8.00M 10-K · filed 2023-03-29 |
| 2021-09-30 | $12.22M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $13.01M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $13.79M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $14.56M 10-K · filed 2022-02-28 |
| 2020-09-30 | $15.30M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $16.01M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $16.71M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $12.24M 10-K · filed 2021-02-24 |
| 2019-09-30 | $10.78M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $11.25M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $11.72M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |